1st Quarter - Report

WILLIAMS AND JENSEN, PLLC for NOVARTIS INC

Firm
Client
Income
$50,000
Expenses
—

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Taxation/Internal Revenue Code TAX

Tax application of ACA section 9008 to orphan drugs.

LobbyistCovered position, as disclosed
CHRISTOPHER W HATCHER —
CHERYL LYNN JAEGER —
GEORGE OLSEN —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Health Issues HCR

Drug importation; drug safety and drug counterfeiting; Authorized generics; Drug company patent settlements; Prescription drug advertising; The Promoting Life Saving New Therapies for Neonates Act; Implementation of the Precision Medicine Initiative; RACE for Children Act; Reauthorization of FDA user fee programs; H.R. 1628, American Health Care Act of 2017; Compassionate use and Right to Try legislation - S. 204 Tribkett Wendler Rights to Try Act of 2017.

LobbyistCovered position, as disclosed
SUSAN HIRSCHMANN —
MATTHEW B HOEKSTRA —
CHERYL LYNN JAEGER —
ANDREW JONES Legislative Counsel, Rep Hinojosa; Legislative Director and Counsel, Rep. Lugan
NICHOLAS KARELLAS New LA to Senator Christopher Bond; Tax Counsel, Rep Lynn Jenkins
KARINA LYNCH —
MELINDA M MAXFIELD —
ERIN BOOK MULLEN —
GEORGE OLSEN —
DAVID A STARR —
FRANK VLOSSAK LA, Rep. Merrill Cook

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 1628 (115th), S. 204 (115th)

Medicare/Medicaid MMM

Medicare prescription drug benefit; Rebates for Medicare Part D; Payment policies for Medicare Part B prescription drugs; the Independent Payment Advisory Board (IPAB); repeal of Part D Non-interference provision.

LobbyistCovered position, as disclosed
SUSAN HIRSCHMANN —
CHERYL LYNN JAEGER —
KARINA LYNCH —
MELINDA M MAXFIELD —
ERIN BOOK MULLEN —
GEORGE OLSEN —
DAVID A STARR —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.